Stock Quote, Chart, News


Symbol Company Name Latest Time Prev Close Latest Price Change $ Change % 52 Wk High 52 Wk Low YTD Chg% Volume
ALLOAllogene TherapeuticsDecember 10, 201826.5226.520.240.9135.5521.676.99621972

News

Morgan Stanley upgrades Teva and Bausch in premarket analyst action


2018-11-05 08:47

Fate Therapeutics (NASDAQ: FATE ) initiated with Buy rating and $17 (15% upside) at Jefferies. More news on: Fate Therapeutics, Inc., Allogene Therapeutics, Alkermes plc, Healthcare stocks news, Stocks on the move, , Read more … ... by SeekingAlpha

Profile

Sector: Healthcare

Industry: Biotechnology

Description:

© Stockaplus.com, All Right Reversed.

Market data provided by IEX Group Inc. The information provided by Stockaplus.com is not investment advice. Trading and investing in financial markets involves risk. You are responsible for your own investment decisions.

New stock charting and analyzer software coming soon, please stay tuned, if you want to go to old site, click Here.